V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016238 | 270008781 | 1.88 | 45 | Palliative (P) | 2017-12-20 | 2018-01-23 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | Y | 270014427 | CETUXIMAB + IRINOTECAN + MDG |
| 270016239 | 270008786 | null | 58 | Palliative (P) | 2014-12-12 | 2014-12-13 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | 270014429 | CETUXIMAB + IRINOTECAN + MDG |
| 270016240 | 270008789 | 1.56 | 63.5 | Palliative (P) | 2015-12-26 | 2016-01-23 | Cetuximab + FOLFIRI cycle 2 onwards | null | null | 270014432 | CETUXIMAB + IRINOTECAN + MDG |
| 270016241 | 270008792 | 1.61 | 79.8 | Curative (C) | 2015-07-17 | 2015-08-13 | BEAM | N | Y | 270014433 | BEAM |
| 270016242 | 270014147 | 1.78 | 33.3 | null | 2016-12-14 | 2017-01-11 | OEPA | 02 | null | 270014444 | OEPA |
| 270016243 | 270019623 | 1.66 | 69 | null | 2018-01-17 | 2018-01-17 | OEPA | N | N | 270014445 | OEPA |
| 270016244 | 270008796 | null | 48.5 | Adjuvant (A) | 2015-08-26 | 2015-09-02 | OEPA | 2 | N | 270014446 | OEPA |
| 270016245 | 270008798 | 1.67 | 73.8 | null | 2015-07-16 | 2016-02-18 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 270014449 | CISPLATIN + RT |
| 270016246 | 270008800 | 1.83 | 86.1 | Curative (C) | 2016-10-02 | 2016-10-04 | HD EuroNet-PHL-C1 OEPA | 02 | N | 270014452 | OEPA |
| 270016247 | 270014151 | null | 67 | Curative (C) | 2014-05-21 | 2014-05-21 | Cisplatin + Radiotherapy | 2 | N | 270014466 | CISPLATIN + RT |
| 270016248 | 270008804 | null | 56.1 | Curative (C) | 2013-11-08 | 2013-11-28 | Rituximab | 2 | Y | 270014467 | RITUXIMAB |
| 270016249 | 270008806 | 1.74 | 65.7 | Curative (C) | 2016-05-25 | 2016-06-07 | BEAM | 02 | N | 270014474 | BEAM |
| 270016252 | 270008814 | 1.74 | 97.5 | Curative (C) | 2013-05-23 | 2013-05-30 | OEPA | N | N | 270014492 | OEPA |
| 270016253 | 270008816 | 1.6 | 29 | Curative (C) | 2017-10-04 | 2017-10-04 | HD EuroNet-PHL-C1 OEPA | null | null | 270014494 | OEPA |
| 270016254 | 270008821 | 1.71 | 74.5 | Curative (C) | 2014-12-16 | 2015-02-04 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014508 | CETUXIMAB + IRINOTECAN + MDG |
| 270016255 | 270008828 | 1.75 | 81 | Curative (C) | 2014-09-05 | 2014-09-06 | Cisplatin + Radiotherapy | 2 | N | 270014515 | CISPLATIN + RT |
| 270016256 | 270014161 | null | 92.9 | Disease modification (D) | 2017-08-08 | 2017-09-14 | LEAM | N | N | 270014520 | LEAM |
| 270016257 | 270019133 | 1.74 | 58.9 | Curative (C) | 2015-07-16 | 2015-07-24 | ESHAP | 02 | null | 270014526 | ESHAP |
| 270016258 | 270008830 | 1.59 | 92.4 | Palliative (P) | 2014-09-18 | 2014-10-17 | BEAM | N | N | 270014528 | BEAM |
| 270016259 | 270008834 | 1.43 | 61.2 | Curative (C) | 2014-05-04 | 2014-05-05 | LEAM | 2 | N | 270014529 | LEAM |
| 270016260 | 270008837 | null | 69 | Curative (C) | 2015-03-19 | 2015-03-30 | ESHAP | null | Y | 270014542 | ESHAP |
| 270016261 | 270008842 | 1.68 | null | Curative (C) | 2016-05-26 | 2016-05-30 | Mini BEAM | null | null | 270014547 | BEAM |
| 270016262 | 270008843 | 1.66 | 67 | Curative (C) | 2014-06-07 | 2014-06-16 | HD EuroNet-PHL-C1 OEPA | null | null | 270014553 | OEPA |
| 270016263 | 270008848 | 1.66 | 69.4 | Disease modification (D) | 2016-12-20 | 2017-05-31 | Rituximab | null | N | 270014555 | RITUXIMAB |
| 270016264 | 270008849 | 1.78 | 89 | Curative (C) | null | 2014-10-19 | ESHAP | N | N | 270014555 | ESHAP |
| 270016266 | 270008854 | 1.88 | 68.2 | Curative (C) | 2014-12-29 | 2014-12-29 | OEPA | N | N | 270014563 | OEPA |
| 270016267 | 270008855 | 1.65 | null | Curative (C) | 2017-09-05 | 2017-11-22 | LEAM | 02 | N | 270014564 | LEAM |
| 270016268 | 270014173 | 1.92 | null | Palliative (P) | 2017-07-24 | 2017-08-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | 270014568 | CETUXIMAB + IRINOTECAN + MDG |
| 270016269 | 270018268 | 1.9 | 71.9 | Curative (C) | null | 2015-01-27 | LEAM | 02 | N | 270014568 | LEAM |
| 270016271 | 270008866 | 1.7 | 74 | Curative (C) | 2016-03-18 | 2016-04-15 | OEPA | 2 | N | 270014581 | OEPA |
| 270016272 | 270008869 | 1.7 | 85.2 | Curative (C) | 2013-03-19 | 2013-12-16 | LEAM | 02 | N | 270014585 | LEAM |
| 270016273 | 270008871 | 1.66 | 74.8 | Curative (C) | 2014-08-18 | 2014-10-15 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270014586 | CISPLATIN + RT |
| 270016274 | 270008873 | 1.79 | 53.3 | Curative (C) | 2017-01-07 | 2017-01-21 | Rituximab | N | N | 270014587 | RITUXIMAB |
| 270016275 | 270014176 | 1.73 | 86 | Curative (C) | 2016-01-15 | 2016-01-27 | Cisplatin + Radiotherapy | 02 | N | 270014590 | CISPLATIN + RT |
| 270016276 | 270016769 | 1.64 | null | Curative (C) | 2016-05-24 | 2016-06-17 | LEAM | 02 | Y | 270014594 | LEAM |
| 270016277 | 270016769 | 1.76 | 100.1 | Adjuvant (A) | 2016-07-23 | 2016-08-16 | OEPA | 02 | N | 270014594 | OEPA |
| 270016278 | 270008881 | 1.59 | 90 | Curative (C) | 2017-08-01 | 2017-08-22 | ESHAP | 2 | N | 270014607 | ESHAP |
| 270016279 | 270019138 | 1.67 | 56.1 | Curative (C) | null | 2016-08-03 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270014608 | OEPA |
| 270016280 | 270008884 | 1.8 | 80 | Curative (C) | 2014-04-19 | 2014-04-19 | CISPLATIN + RT | N | N | 270014610 | CISPLATIN + RT |
| 270016281 | 270008886 | 1.66 | 71.4 | Palliative (P) | 2014-08-02 | 2014-08-22 | Cetuximab + FOLFIRI cycle1 | 02 | N | 270014619 | CETUXIMAB + IRINOTECAN + MDG |
| 270016282 | 270014181 | 1.77 | 90.5 | Curative (C) | 2016-01-08 | 2016-01-13 | OEPA | N | null | 270014620 | OEPA |
| 270016283 | 270008888 | 1.13 | null | Curative (C) | 2014-05-05 | 2015-01-09 | Rituximab | 02 | N | 270014622 | RITUXIMAB |
| 270016284 | 270008890 | 1.87 | 47.1 | Curative (C) | 2014-01-29 | 2014-03-24 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 270014624 | CETUXIMAB + IRINOTECAN + MDG |
| 270016285 | 270018273 | 0 | 92.8 | Curative (C) | 2014-07-31 | 2015-04-14 | LEAM | 02 | N | 270014625 | LEAM |
| 270016286 | 270008895 | 1.78 | 90.8 | Curative (C) | 2016-10-25 | 2016-11-09 | LEAM | 01 | N | 270014625 | LEAM |
| 270016287 | 270008896 | null | 72.5 | Palliative (P) | 2017-10-03 | 2017-10-05 | CETUXIMAB + IRINOTECAN + MDG | null | null | 270014627 | CETUXIMAB + IRINOTECAN + MDG |
| 270016288 | 270016776 | 1.84 | 62 | Curative (C) | 2015-04-10 | 2015-05-01 | CISPLATIN + RT | N | N | 270014631 | CISPLATIN + RT |
| 270016289 | 270014188 | 1.81 | 97 | Palliative (P) | 2016-02-08 | 2016-02-22 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014639 | CETUXIMAB + IRINOTECAN + MDG |
| 270016290 | 270008903 | 1.75 | 109.3 | Curative (C) | null | 2016-12-01 | ESHAP | null | null | 270014641 | ESHAP |
| 270016291 | 270008906 | 1.65 | 55.1 | Curative (C) | 2016-10-18 | 2016-10-28 | ESHAP | N | N | 270014646 | ESHAP |